Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
# MC2030
Chicago, IL 60637Phone+1 773-702-1061
Education & Training
- NIH Clinical CenterPost-Doctoral Fellowship, 2002 - 2007
- Memorial Sloan Kettering Cancer CenterFellowship, 2000 - 2002
- University of ChicagoChief Residency, Neurology, 1999 - 2000
- University of ChicagoResidency, Neurology, 1997 - 2000
- University of Chicago (NorthShore)Internship, Transitional Year, 1996 - 1997
- Loma Linda University School of MedicineClass of 1996
- Loma Linda UniversityFellowship, 1993 - 1994
Certifications & Licensure
- IL State Medical License 2018 - 2026
- NJ State Medical License 2023 - 2025
- PA State Medical License 2007 - 2010
- NY State Medical License 2000 - 2008
- American Board of Psychiatry and Neurology Neurology
- United Council for Neurologic SubspecialtiesNeuro-Oncology
Awards, Honors, & Recognition
- Merit and Career Development Awards American Society of Clinical Oncology
Clinical Trials
- Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma Start of enrollment: 2011 Oct 01
- QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma Start of enrollment: 2015 May 01
- Biomarker Analysis of Central Nervous System Tumors Start of enrollment: 2016 Feb 25
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsNAD+ Metabolic Enzyme Inhibitor as Radiosensitizer for Malignant Meningioma and its Modulation of P53 Expression.Yifan Lv, Yuxuan Deng, Jie Feng, Jinqiu Liu, Mingxu Yang
Molecular Cancer Therapeutics. 2024-11-04 - 3 citationsrWTC-MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells.Herui Wang, Rogelio Medina, Juan Ye, Yaping Zhang, Samik Chakraborty
Advanced Science. 2024-04-01 - TGF-β and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcoma.Aiguo Li, John C Hancock, Martha Quezado, Susie Ahn, Nicole Briceno
Neuro-Oncology Advances. 2023-12-19
Journal Articles
- Clinical Decision Making in the Era of Immunotherapy for High Grade-Glioma: Report of Four CasesMartha Quezado, Brett J Theeler, Deric M Park, Edjah Nduom, Nancy Garren, Surabhi Ranjan, Kareem A Zaghloul, BioMed Central
Professional Memberships
- Fellow
Other Languages
- Korean
Industry Relationships
- Scientific Advisor, Innate Repair2018 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: